Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Net Income: 2010-2025

Historic Net Income for OptimizeRx (OPRX) over the last 16 years, with Q3 2025 value amounting to $779000.0.

  • OptimizeRx's Net Income rose 10853.79% to $779000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year increase of 11520.25%. This contributed to the annual value of -$15.3 million for FY2024, which is 1282.02% up from last year.
  • As of Q3 2025, OptimizeRx's Net Income stood at $779000.0, which was up 10853.79% from $1.5 million recorded in Q2 2025.
  • In the past 5 years, OptimizeRx's Net Income registered a high of $4.7 million during Q4 2024, and its lowest value of -$11.7 million during Q4 2023.
  • For the 5-year period, OptimizeRx's Net Income averaged around -$2.7 million, with its median value being -$2.9 million (2023).
  • Per our database at Business Quant, OptimizeRx's Net Income crashed by 879000.85% in 2022 and then soared by 14018.74% in 2024.
  • Over the past 5 years, OptimizeRx's Net Income (Quarter) stood at $623462.0 in 2021, then tumbled by 152.26% to -$325836.0 in 2022, then plummeted by 3503.04% to -$11.7 million in 2023, then surged by 140.19% to $4.7 million in 2024, then tumbled by 83.49% to $779000.0 in 2025.
  • Its Net Income stands at $779000.0 for Q3 2025, versus $1.5 million for Q2 2025 and -$2.2 million for Q1 2025.